1.Primary Biliary Cirrhosis.
Chae Yoon CHON ; Jun Yong PARK
The Korean Journal of Hepatology 2006;12(3):364-372
Primary biliary cirrhosis (PBC) is a chronic cholestatic autoimmune liver disease that predominantly affects middle-aged women. It is characterized by slowly progressive destruction of the small intrahepatic bile ducts together with portal inflammation, and this initially leads to fibrosis and later to cirrhosis. It is currently accepted that the pathogenesis of PBC is multifactorial with genetic and environmental factors interplaying to determine the disease onset and progression. In addition to antimitochondrial antibody (AMA), which is the hallmark of PBC and is detected in at least 90% of the patients, other autoantibodies (antinuclear antibody, anti-smooth muscle antibody and rheumatoid factor, etc.) may also be found in the patients. There is no correlation between the titer of AMAs and the disease severity. Most patients are diagnosed either during the asymptomatic phase of PBC or after presenting with non-specific symptoms. Pruritus and fatigue are the most common symptoms of PBC. The prognosis of PBC has improved significantly during the last few decades. Patients are now diagnosed earlier in its clinical course, they are more likely to be asymptomatic at diagnosis and they are more likely to receive medical treatment. A wide variety of drugs have been assessed for the treatment of this condition: such immunosuppressive agents as corticosteroids, cyclosporine and azathioprine have a weak effect on the disease's natural history. Ursodeoxycholic acid (UDCA) is the only currently approved medical treatment. For PBC patients with end-stage liver disease or an unacceptable quality of life, liver transplantation is the only accepted therapeutic option. Early diagnosis and treatment of PBC are important because effective treatment with UDCA has been shown to delay disease progression and improve rate survival in the early stage.
Autoimmune Diseases/*diagnosis/*drug therapy/epidemiology
;
Cholagogues and Choleretics/*therapeutic use
;
Cholestadienes/administration & dosage/therapeutic use
;
Cholic Acids/administration & dosage/therapeutic use
;
Female
;
Humans
;
Liver Cirrhosis, Biliary/*diagnosis/*drug therapy/epidemiology
;
Male
;
Middle Aged
;
Prevalence
;
Rifampin/administration & dosage/therapeutic use
2.A Multicenter Retrospective Analysis of the Clinical Features of Pernicious Anemia in a Korean Population.
Ik Chan SONG ; Hyo Jin LEE ; Han Jo KIM ; Sang Byung BAE ; Kyu Taek LEE ; Young Jun YANG ; Suk Young PARK ; Do Yeun CHO ; Nae Yu KIM ; In Sung CHO ; Deog Yeon JO
Journal of Korean Medical Science 2013;28(2):200-204
To determine the approximate incidence and clinical features of pernicious anemia in a Korean population, we retrospectively analyzed clinical data for patients with pernicious anemia who were diagnosed between 1995 and 2010 at five hospitals in Chungnam province. Ninety-seven patients were enrolled, who accounted for 24% of patients with vitamin B12 deficiency anemia. The approximate annual incidence of pernicious anemia was 0.3 per 100,000. The median age was 66 (range, 32-98) yr, and the male/female ratio was 1.25. Anemia-associated discomfort was the most common symptom (79.4%), followed by gastrointestinal and neurological symptoms (78.4% and 38.1%, respectively). Pancytopenia was found in 36 patients (37.1%), and autoimmune disorders were found in 15 patients (15.5%). Antibody to intrinsic factor was detected in 62 (77.5%) of 80 patients examined, and antibody to parietal cells was detected in 35 (43.2%) of 81 patients examined. Of the 34 patients who underwent tests for Helicobacter pylori, 7 (12.5%) were positive. The anemia-associated and gastrointestinal symptoms resolved completely in all patients after intramuscular injection of cobalamin, whereas neurological symptoms remained in some. In conclusion, pernicious anemia is less frequent in Koreans than in Western populations; however, the clinical features of this disorder in Koreans do not differ from those of Western cases.
Adult
;
Aged
;
Anemia, Pernicious/complications/*diagnosis/epidemiology
;
Asian Continental Ancestry Group
;
Autoimmune Diseases/complications/epidemiology
;
Female
;
Gastrointestinal Diseases/complications/drug therapy/epidemiology
;
Helicobacter Infections/diagnosis
;
Helicobacter pylori
;
Humans
;
Isoantibodies/blood
;
Male
;
Middle Aged
;
Nervous System Diseases/complications/epidemiology
;
Parietal Cells, Gastric/immunology
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Vitamin B 12/blood/therapeutic use